Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Glenmark Life Sciences IPO.
July 11, 2024 6:59:00 PM
Shares of Glenmark Life Sciences slumped as much as nearly 4 percent on July 11, a day after Glenmark Pharma's board greenlit the company's plans to offload a 7.84 percent stake in the former through ...
Published by : moneycontrol.com on MSNJuly 10, 2024 1:55:49 PM
Glenmark Pharma said on July 10 that its board approved selling 7.84 percent stake in Glenmark Life Sciences through an offer for sale. "We wish to inform you that the Board of Directors, at its ...
Published by : Moneycontrol on MSNJuly 10, 2024 5:45:00 PM
Glenmark Pharmaceuticals announced the sale of its remaining 7.84% stake in Glenmark Life Sciences through an offer for sale, valued around Rs 778 crore. The shares, priced at Rs 810 each, will be ...
Published by : devdiscourseJuly 5, 2024 10:31:06 AM
"Another stock what we are liking is Glenmark Life Sciences. This is one API company which has ... so this is another stock which we have been liking, the IPO although it had come last year but we are ...
Published by : The Economic Times on MSNThe IPO Shares of Glenmark Life Sciences Limited IPO are proposed to list on Friday, August 6, 2021 at BSE, NSE. The public issue of Glenmark Life Sciences IPO was opened on Jul 27, 2021 and closed for subscription on Jul 29, 2021. Glenmark Life Sciences IPO Listing Date and Information:
| Listing Date | Friday, August 6, 2021 |
| BSE Script Code | 543322 |
| NSE Symbol | GLS |
| Listing In | B Group of Securities |
| ISIN | INE03Q201024 |
| Issue Price | ₹720 Per Equity Share |
| Face Value | ₹2 Per Equity Share |
The allotment status of Glenmark Life Sciences Limited IPO is now available online. The public issue of Glenmark Life Sciences IPO was open on Jul 27, 2021 and closed for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE
.
Glenmark Life Sciences Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 2 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs - Rs Per Equity Share.
Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
The issue opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Glenmark Life Sciences Limited opens on Jul 27, 2021 and closes for subscription on Jul 29, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.
The Glenmark Life Sciences IPO is proposed to open on July 27, 2021. The IPO application ends on July 29, 2021.
Retail investors can apply in the retail or non-institutional investor category from July 27, 2021 to July 29, 2021. The Glenmark Life Sciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Glenmark Life Sciences IPO will open for subscription on July 27, 2021. The public issue will close on July 29, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
